|
Written by ActiGraph |
Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration. This infographic provides a snapshot of the current state of cancer drug research, the use of motion-tracking wearables within oncology clinical trials, and the benefits and opportunities that digital endpoint data offers within this challenging therapeutic area.
Watch the On-Demand Webinar
ActiGraph CEO, Jeremy Wyatt joins a panel of thought leaders from VivoSense, Covance, Keck School of Medicine of USC, and Moffitt Cancer Center to discuss how they are successfully deploying wearable and remote monitoring technologies to improve clinical outcomes in patients living with cancer. They also discuss the reasons behind, and the missed opportunities from, the slow adoption of such tools.
Interested in receiving more articles like this?